Dressbarn confirms 53 stores to close in August as wind down nears

Dressbarn confirms 53 stores to close in August as wind down nears

Date: 2019-07-20 By Pankaj Singh

Ascena shares have been down by more than 75% this year and are trading at below $1 Ascena Retail Group, an American retailer for women’s clothing, recently announced that it is going to shut down 53 locations of ....

Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical company focused on developing protein therapeutics, has recently announced t....

LifeSpan Bio acquires Everest Biotech to expand reagent portfolio

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of life science research reagents and antibodies, has recently announced that i....

AbbVie buys Mavupharma to target STING pathway for cancer treatment

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon Genes pathway for the t....

Japan introduces working group to examine impact of Facebook’s Libra

Japan is looking to garner greater support due to the wide range of policies which can be affected by digital currencies. Japanese authorities have reportedly established a working group to discuss the impact Libra digital coin proposed by....

Motorola Solutions buys WatchGuard to expand video security portfolio

WatchGuard’s solutions allow law enforcement users to manage high-quality video evidence Motorola Solutions, Inc., the US based data communications and telecommunications equipment provider, has recently announced the acquisition of ....

Ligand Pharma announces positive results from trial of CE-Iohexol

Ligand Pharmaceuticals, a US-based biopharmaceutical company recently announced positive top line results from clinical trial of its internal CE (Captisol-enabled) Iohexol program. The study attained primary endpoint indicating pharmac....